Hypoactive Sexual Desire Disorder
📧 Sign up to get email alerts when something new happens for Hypoactive Sexual Desire Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]
Phase 3 trial evaluating 100 mg flibanserin taken every evening versus placebo in premenopausal women with hypoactive sexual desire disorder…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]
Phase 3 safety study of flibanserin in pre- and postmenopausal women with hypoactive sexual desire disorder was terminated; results were pos…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder [Phase 2]
Clinical trial update reporting Phase 2 results for Bremelanotide in premenopausal women with female sexual arousal disorder or hypoactive s…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems [Phase 2]
Phase 2 clinical trial of Lybridos for hypoactive Sexual Desire Disorder in pre- and postmenopausal women has completed. The document does n…
-
CLINICAL_TRIALS trial_result · 2013-07-29Clinical Trial Update: Lybrido for Female Sexual Dysfunction [Phase 2]
Phase 2 trial of Lybrido for hypoactive sexual desire disorder in women has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido [Phase 3]
Phase 3 study evaluating transdermal testosterone patches for hypoactive sexual desire disorder in naturally menopausal women has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido [Phase 3]
Phase 3 study of transdermal testosterone patches in menopausal women with hypoactive sexual desire disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido [Phase 3]
A Phase 3 study evaluating transdermal testosterone patches for surgically menopausal women with hypoactive sexual desire disorder has compl…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen [Phase 3]
Phase 3 trial evaluating testosterone therapy for hypoactive sexual desire disorder in naturally menopausal women receiving transdermal estr…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of transdermal testosterone patches in naturally menopausal women with hypoactive sexual …
-
CLINICAL_TRIALS research · 2013-04-17Clinical Trial Update: Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido [Phase 3]
Phase 3 trial evaluating transdermal testosterone patches for hypoactive sexual desire disorder in surgically menopausal women has completed…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women [Phase 3]
A Phase 3 clinical trial evaluating LibiGel for hypoactive sexual desire disorder in surgically menopausal women has completed. The update i…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of LibiGel for hypoactive sexual desire disorder in surgically menopausal women has compl…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) [Phase 3]
This update describes a completed Phase 3 extension study to assess how long the benefits of LibiGel last for Hypoactive Sexual Desire Disor…
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD) [Phase 1]
Phase 1 pharmacokinetic study of Flibanserin in postmenopausal women with hypoactive sexual desire disorder, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women [Phase 3]
Phase 3 randomized withdrawal trial of flibanserin in premenopausal women has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-15Clinical Trial Update: Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women [Phase 3]
Phase 3 endometrial safety study of a 300 mcg/day transdermal testosterone in naturally postmenopausal women with hypoactive sexual desire d…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa® [Phase 1]
Phase 1 pharmacokinetic study comparing absorption of two formulations of transdermal testosterone spray and Intrinsa was terminated.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality
A clinical trial investigating psycho-pharmacological and brain imaging approaches to human sexuality has been suspended. It concerns hypoac…
-
CLINICAL_TRIALS research · 2009-12-01Clinical Trial Update: Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder [NA]
This clinical trial update reports on Dehydroepiandrosterone (DHEA) treatment for Hypoactive Sexual Desire Disorder, with current status lis…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Testosterone in Female Hypoactive Sexual Desire Disorder [Phase 3]
Phase 3 clinical trial evaluating testosterone for hypoactive sexual desire disorder in women has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-29Clinical Trial Update: Sexual Dysfunction and Dental Care
A completed clinical trial update from Sheba Medical Center examines the relationship between dental care and sexual dysfunction, covering d…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction [Phase 2]
Phase 2 study of Ginkgo Biloba for antidepressant-induced sexual dysfunction has completed.